Adult Advanced Life Support (ACLS) 2025 Updates – Evidence-Based Refinements for Modern Resuscitation Practice

Structured clinical summary of the major positive and negative updates, with Class of Recommendation (COR) and Level of Evidence (LOE).

The 2025 Adult Advanced Life Support guidelines released by the American Heart Association introduce important clarifications and evidence-driven adjustments in defibrillation strategy, airway and vascular access, medication use, physiologic monitoring, and advanced technologies.

The overarching theme remains consistent: prioritize high-quality CPR and early defibrillation, avoid unproven adjuncts, and focus on physiology-guided resuscitation.

1. Defibrillation Strategy – Refined, Not Reinvented

Shockable rhythms (VF/pVT)

• Biphasic waveform defibrillation preferred over monophasic
COR 2a | LOE B-R

• Single-shock strategy remains preferred (no stacked shocks)
COR 2a | LOE B-NR

• Escalating energy for subsequent shocks may be considered when initial shock fails
COR 2b | LOE B-R

Clinical implication:
Minimize CPR interruptions and follow manufacturer-recommended energy settings.

2. Vector Change & Double Sequential Defibrillation (DSD)

👉 Usefulness in persisting VF/pVT after ≥3 shocks remains unestablished

• Vector change: COR 2b | LOE B-R
• Double sequential defibrillation: COR 2b | LOE B-R

Key message:
Routine adoption is not supported at this time. Most post-shock VF is due to recurrence, not failed defibrillation.

Focus should remain on:

• High-quality CPR
• Adequate energy delivery
• Rhythm stabilization (antiarrhythmics)

3. Head-Up CPR

❌ Not recommended outside rigorously controlled clinical trials

COR 3 (No Benefit) | LOE C-LD

Despite physiologic appeal, current evidence does not support routine clinical use.

4. Electrical Pacing During Cardiac Arrest

❌ Routine transcutaneous, transvenous, or transmyocardial pacing is NOT recommended

COR 3 (No Benefit) | LOE B-R

Clinical insight:
Pacing does not improve ROSC or survival and may interrupt effective CPR.

5. Vascular Access – Clear Hierarchy Now Established

First-line:

👉 Intravenous (IV) access

COR 1 | LOE A

If IV not feasible or delayed:

👉 Intraosseous (IO) access is reasonable

COR 2a | LOE A

Central venous access:

👉 May be considered by trained providers when IV/IO unsuccessful

COR 2b | LOE C-LD

Practice focus:
Do not delay drug delivery in pursuit of difficult IV access.

6. Advanced Airway & Ventilation

Core principles reinforced:

• Avoid hyperventilation
• Use waveform capnography to confirm tube placement and monitor CPR quality

ETCO₂ is useful for:

✔ Assessing compression quality
✔ Identifying ROSC

❗ But should NOT be used alone to terminate resuscitation

7. Physiologic & Technology-Guided Resuscitation

POCUS (Point-of-care ultrasound)

👉 May be considered by experienced providers to identify reversible causes

COR 2b | LOE C-LD

⚠ Must not interrupt chest compressions

Useful for detecting:

• Tamponade
• Massive PE
• Hypovolemia
• Tension pneumothorax

ECG artifact-filtering & VF waveform analysis

👉 Effectiveness not established for guiding real-time management

COR 2b | LOE C-LD

These remain research tools, not standard of care.

8. Cardioversion for Unstable Tachyarrhythmias

👉 Higher initial energy (≥200 J) preferred for atrial fibrillation/flutter

Improves first-shock success and rhythm conversion.

9. Medication Principles (Reinforced)

• Epinephrine remains central in nonshockable arrest
• Antiarrhythmics (amiodarone or lidocaine) remain reasonable for refractory VF/pVT
• Drug delivery should not delay core interventions

Key “DO NOT ROUTINELY USE” Updates

• Double sequential defibrillation (routine)
• Vector change strategies (routine)
• Head-up CPR
• Electrical pacing during arrest
• Waveform-guided defibrillation algorithms

Clinical Takeaways from ACLS 2025

• High-quality CPR and early defibrillation remain dominant survival drivers
• Biphasic shocks + minimal interruptions are essential
• Most “refractory VF” represents recurrence, not failed shock
• Advanced technologies are adjuncts — not replacements for fundamentals
• IV first, IO second for rapid drug delivery
• Avoid unproven electrical strategies

Bottom Line

The 2025 ACLS updates emphasize precision over novelty:

✔ Do the basics exceptionally well
✔ Use evidence-supported adjuncts thoughtfully
❌ Avoid complex interventions without proven benefit

Resuscitation success continues to depend far more on CPR quality, rapid defibrillation, and system efficiency than on experimental techniques.

Source:
Part 9: Adult Advanced Life Support: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care